Log in
Congenital malformations

Turner syndrome

Turner syndrome is a genetic disorder caused by complete or partial absence of one X chromosome in phenotypic females, affecting approximately 1 in 2,000 to 2,500 live female births. Affected individuals typically present with short stature, gonadal dysgenesis leading to infertility, and characteristic physical features. The most testable fact is that short stature and primary amenorrhea with streak ovaries are the cardinal features.

Practice questionsHigh-yield facts
ICD-10Q96
Typical patientAdolescent girl with short stature and delayed puberty
Key findingStreak ovaries with elevated FSH and LH
First-line treatmentGrowth hormone therapy and estrogen replacement
12 min readFor medical studentsUpdated 2026-10-14

Definition and epidemiology

Turner syndrome is a chromosomal disorder characterized by complete or partial absence of one X chromosome in individuals with a female phenotype. The condition results from monosomy X (45,X) in approximately 50-60% of cases, while the remainder have mosaicism (45,X/46,XX) or structural abnormalities of the X chromosome such as isochromosome, ring chromosome, or partial deletions.

The incidence is approximately 1 in 2,000 to 2,500 live-born females, making it one of the most common sex chromosome abnormalities. However, Turner syndrome accounts for approximately 10% of all first-trimester spontaneous abortions, as about 99% of 45,X conceptions result in miscarriage. The condition occurs sporadically and is not associated with advanced maternal age. It affects all ethnic groups and geographic populations equally.

Most cases are diagnosed during adolescence when short stature becomes apparent or primary amenorrhea prompts evaluation. However, prenatal diagnosis is increasingly common through cell-free DNA screening or diagnostic testing. Early childhood diagnosis may occur when cardiac anomalies or lymphedema are detected.

High-yield for exams
  • Turner syndrome: 45,X karyotype with short stature and streak ovaries; most common sex chromosome abnormality in live-born females
  • Short stature (>95%) and primary amenorrhea (90%) are cardinal features; SHOX gene haploinsufficiency causes growth impairment
  • Elevated FSH and LH with low estradiol confirm gonadal dysgenesis; diagnosis by karyotype showing 45,X or mosaicism
  • Bicuspid aortic valve (30%) and coarctation of aorta (10-15%) are most common cardiac defects; aortic dissection is leading cause of death
  • Growth hormone therapy started age 4-6 increases final height by 5-10 cm; estrogen replacement begun around age 11-12
  • Horseshoe kidney is most common renal anomaly; hypothyroidism affects 15-30%; celiac disease risk increased 3-6 fold
  • Pregnancy is high-risk with 2% aortic dissection risk; maternal mortality 100-fold higher; cardiovascular evaluation mandatory before conception
  • Life expectancy reduced by 10-13 years; cardiovascular disease accounts for 40% of excess mortality; lifelong surveillance essential

Etiology and risk factors

Turner syndrome results from complete or partial loss of one X chromosome. The 45,X karyotype (complete monosomy) accounts for 50-60% of cases. Mosaicism (two or more cell lines, such as 45,X/46,XX) occurs in 15-25% of patients and may result in milder phenotypic features. Structural X chromosome abnormalities including isochromosome Xq, ring X chromosome, and partial deletions of Xp or Xq make up the remaining cases.

The parental origin of the retained X chromosome varies, but when determined, the maternal X is retained in approximately 70-80% of cases. This suggests that errors during paternal meiosis or early post-zygotic mitotic events are the primary mechanisms.

Risk factors:

  • Sporadic occurrence: Turner syndrome arises de novo and is not inherited. There is no increased recurrence risk in families.
  • Maternal age: Unlike trisomies, Turner syndrome shows no association with advanced maternal age.
  • No known environmental factors: No environmental exposures or parental behaviors have been linked to increased risk.

The key genes responsible for the Turner phenotype are located on the short arm of the X chromosome (Xp), particularly the SHOX gene (short stature homeobox-containing gene), which escapes X-inactivation and is haploinsufficient in Turner syndrome, contributing to short stature and skeletal abnormalities.

Pathophysiology

The pathophysiology of Turner syndrome stems from haploinsufficiency of genes on the X chromosome that normally escape X-inactivation. These genes are expressed from both X chromosomes in typical females, so loss of one X chromosome results in reduced gene dosage.

Key pathophysiologic mechanisms:

Short stature

Haploinsufficiency of the SHOX gene on Xp leads to impaired linear growth. SHOX encodes a transcription factor critical for chondrocyte development and growth plate function. Loss of one copy results in shortened long bones, particularly in the legs, and contributes to skeletal abnormalities including Madelung deformity.

Gonadal dysgenesis

Accelerated germ cell loss occurs during fetal development and early childhood. While ovaries initially form normally, oocytes undergo accelerated atresia, leaving only fibrous tissue (streak gonads) by adolescence. This results from haploinsufficiency of multiple X-linked genes required for oocyte survival. The absence of functional ovarian tissue leads to:

  • Primary ovarian insufficiency with absent pubertal development
  • Elevated gonadotropins (FSH, LH) due to lack of negative feedback
  • Low estrogen levels causing absent secondary sexual characteristics
  • Infertility in most cases

Cardiovascular anomalies

Cardiac malformations occur in 25-50% of patients. The most common are bicuspid aortic valve (30%), coarctation of the aorta (10-15%), and aortic root dilation. These arise from abnormal neural crest cell migration and vascular remodeling during embryogenesis.

Lymphatic abnormalities

Fetal lymphatic obstruction leads to cystic hygroma, nuchal edema, and peripheral lymphedema at birth. This results from impaired lymphatic vessel development.

Renal anomalies

Structural kidney defects including horseshoe kidney, duplicated collecting systems, and renal hypoplasia occur in approximately 30-40% of cases due to disrupted embryologic kidney development.

Clinical features

The clinical presentation of Turner syndrome varies widely depending on the specific karyotype, with mosaic forms generally exhibiting milder features. Short stature and gonadal dysgenesis are the most consistent findings.

Cardinal features:

  • Short stature: Present in >95% of patients. Average adult height without treatment is 143 cm (4 feet 8 inches), approximately 20 cm below the population mean. Growth velocity is normal until age 3, then progressively falls below normal.
  • Gonadal dysgenesis: Streak ovaries lead to primary amenorrhea in 90% of cases. Spontaneous puberty occurs in 10-20%, typically in mosaic patients, but premature ovarian failure usually follows.

Physical examination findings:

Dysmorphic features

  • Low posterior hairline
  • Webbed neck (pterygium colli) in 25-40%
  • High-arched palate
  • Micrognathia (small jaw)
  • Low-set, posteriorly rotated ears
  • Epicanthal folds and ptosis
  • Shield chest with widely spaced nipples
  • Cubitus valgus (increased carrying angle of arms)
  • Short fourth metacarpals
  • Hyperconvex nails
  • Multiple pigmented nevi

Cardiovascular

  • Bicuspid aortic valve (30%)
  • Coarctation of the aorta (10-15%)
  • Aortic stenosis
  • Partial anomalous pulmonary venous return
  • Hypoplastic left heart (rare)
  • Hypertension (even without coarctation)

Renal

  • Horseshoe kidney (most common)
  • Renal aplasia or hypoplasia
  • Duplicated collecting system
  • Malrotation

Endocrine

  • Hypothyroidism (15-30%)
  • Glucose intolerance and type 2 diabetes (increased risk)
  • Obesity (tendency in adulthood)

Skeletal

  • Madelung deformity (bowing of radius)
  • Scoliosis and kyphosis
  • Osteoporosis (due to estrogen deficiency)

Other

  • Recurrent otitis media and conductive hearing loss
  • Sensorineural hearing loss (progressive)
  • Celiac disease (increased prevalence)
  • Inflammatory bowel disease (slight increase)
  • Lymphedema of hands and feet at birth

Diagnosis

Turner syndrome should be suspected in any girl or woman presenting with unexplained short stature, delayed puberty, or primary amenorrhea. Diagnosis is confirmed by karyotype analysis.

Diagnostic approach:

Karyotype analysis

Chromosomal analysis (karyotype) is the gold standard diagnostic test. Peripheral blood lymphocyte analysis is typically sufficient, but if mosaicism is suspected and initial testing shows 46,XX, additional tissue sampling (buccal cells or skin fibroblasts) may be indicated. At least 20-30 cells should be analyzed to detect low-level mosaicism. Karyotype reveals:

  • 45,X in 50-60%
  • Mosaicism (45,X/46,XX or other) in 15-25%
  • Structural X abnormalities in 15-25%

Hormonal evaluation

  • Elevated FSH and LH: Gonadotropins are markedly elevated (FSH >30-40 IU/L) due to absent negative feedback from dysgenic ovaries, particularly after age 10-11.
  • Low estradiol: Estradiol levels are in the prepubertal range in untreated adolescents and adults.
  • Anti-Müllerian hormone (AMH): Undetectable or very low, reflecting absent ovarian follicles.

Additional baseline investigations

Once diagnosis is confirmed, comprehensive screening for associated anomalies is indicated:

  • Echocardiography: To detect cardiac malformations, especially bicuspid aortic valve and coarctation
  • Cardiac MRI or CT: For detailed aortic evaluation if echocardiography is suboptimal
  • Renal ultrasound: To identify structural kidney anomalies
  • Thyroid function tests (TSH, free T4): Screen for hypothyroidism
  • Celiac screening (tissue transglutaminase antibodies): Increased prevalence of celiac disease
  • Liver function tests: Baseline assessment
  • Fasting glucose and HbA1c: Diabetes screening
  • Bone age radiograph: Typically delayed 2-3 years
  • Audiology evaluation: Assess for hearing loss

Prenatal diagnosis

Turner syndrome may be detected prenatally through:

  • Cell-free DNA screening (shows monosomy X, but requires confirmation)
  • Increased nuchal translucency on first-trimester ultrasound
  • Cystic hygroma, hydrops fetalis, or cardiac anomalies on fetal ultrasound
  • Amniocentesis or chorionic villus sampling with karyotype

Differential diagnosis

Several conditions may present with overlapping features and should be considered in the differential diagnosis:

Short stature differentials:

  • Noonan syndrome: Shares many physical features including webbed neck, cardiac defects (especially pulmonary stenosis), and short stature. Distinguished by normal female karyotype (46,XX), presence in males, normal or early puberty, and mutations in RAS/MAPK pathway genes.
  • Constitutional growth delay: Family history of delayed puberty and "late bloomers," normal growth velocity, delayed bone age, eventual normal adult height.
  • Growth hormone deficiency: Proportionate short stature with low IGF-1 and abnormal growth hormone stimulation test. No dysmorphic features.
  • Hypothyroidism: Growth delay with elevated TSH, low T4, and clinical features of thyroid deficiency.

Primary amenorrhea differentials:

  • Androgen insensitivity syndrome: 46,XY karyotype with female external genitalia, absent uterus, and inguinal gonads. Patients are taller than average.
  • Kallmann syndrome: Isolated hypogonadotropic hypogonadism with anosmia. Low gonadotropins (unlike Turner's elevated levels).
  • Pure gonadal dysgenesis (Swyer syndrome): 46,XY with female phenotype and streak gonads, but normal height.
  • Premature ovarian insufficiency: Occurs in older adolescents or young women with prior normal puberty and menstrual cycles.
  • Polycystic ovary syndrome: Secondary amenorrhea with hyperandrogenism, normal or tall stature.

Cardiac anomaly differentials:

  • Williams syndrome: Supravalvular aortic stenosis, characteristic facies, developmental delay, hypercalcemia.
  • 22q11.2 deletion syndrome (DiGeorge): Conotruncal heart defects, hypocalcemia, immune deficiency, developmental delays.

Lymphedema differentials:

  • Noonan syndrome
  • Lymphedema-distichiasis syndrome
  • Primary lymphedema (Milroy disease)

Key distinguishing feature: Karyotype analysis definitively distinguishes Turner syndrome (45,X or variants) from all other conditions.

Management

Management of Turner syndrome requires lifelong multidisciplinary care addressing growth, pubertal development, associated medical conditions, and psychosocial support.

Growth hormone therapy

Recombinant human growth hormone is first-line treatment to improve final adult height. Treatment should begin when height velocity declines, typically between ages 4-6 years, and continue until near-final height is reached or growth velocity falls below 2 cm/year. Growth hormone therapy can increase final adult height by approximately 5-10 cm. Higher doses are used than in growth hormone deficiency. Treatment is approved specifically for Turner syndrome and does not require documented growth hormone deficiency.

Hormone replacement therapy

Estrogen replacement is essential to induce pubertal development and maintain bone health. Initiation timing is individualized:

  • Typically started around age 11-12 years to approximate normal pubertal timing
  • Begin with very low-dose estrogen (oral or transdermal) to promote gradual breast development and optimize final height
  • Gradually increase dose over 2-3 years to adult replacement levels
  • Add progestin (e.g., medroxyprogesterone or micronized progesterone) once breakthrough bleeding occurs or after 2 years of estrogen to protect the endometrium
  • Continue lifelong unless contraindications arise

Estrogen therapy prevents osteoporosis, supports cardiovascular health, and promotes normal pubertal development and sexual function.

Cardiovascular management

  • Regular surveillance: Echocardiography every 3-5 years in childhood, then every 5-10 years in adulthood if no abnormalities; more frequent if abnormalities detected
  • Aortic monitoring: Cardiac MRI every 5-10 years to assess aortic dimensions in adults
  • Blood pressure control: Aggressive hypertension management; target BP <130/80 mmHg
  • Surgical intervention: For severe coarctation, significant aortic stenosis, or progressive aortic dilation
  • Endocarditis prophylaxis: For patients with bicuspid aortic valve undergoing dental procedures (guidelines vary by region)
  • Activity restrictions: Avoid contact sports if significant aortic dilation; individualized based on cardiovascular status

Fertility and reproductive health

Most women with Turner syndrome are infertile due to gonadal dysgenesis. Options include:

  • Oocyte donation with in vitro fertilization: Successful pregnancy rates are comparable to other IVF recipients, but maternal risks are significantly elevated
  • Fertility preservation: Extremely rare cases with spontaneous puberty and mosaic karyotype may have oocytes available for cryopreservation
  • Pregnancy counseling: Women considering pregnancy require extensive pre-pregnancy cardiovascular evaluation due to high risk of aortic dissection and maternal mortality. Pregnancy is contraindicated if aortic diameter exceeds specific thresholds.

Screening and management of comorbidities

  • Thyroid: TSH screening annually; treat hypothyroidism with levothyroxine
  • Glucose metabolism: Fasting glucose or HbA1c screening every 1-2 years; lifestyle modification and metformin or other agents if diabetes develops
  • Celiac disease: Screen with tissue transglutaminase antibodies at diagnosis and if symptoms develop
  • Bone health: DEXA scan in late adolescence; calcium and vitamin D supplementation; weight-bearing exercise
  • Audiology: Hearing assessment every 3-5 years; treat otitis media promptly; consider hearing aids if sensorineural loss develops
  • Ophthalmology: Screen for strabismus, ptosis, and refractive errors
  • Liver function: Monitor transaminases; investigate if elevated

Psychosocial support

  • Educational support and neuropsychological assessment if learning difficulties present
  • Counseling regarding diagnosis, infertility, and body image concerns
  • Support groups and connection with Turner syndrome community

Transition to adult care

Comprehensive transition planning should begin in mid-adolescence with gradual transfer to adult specialists familiar with Turner syndrome by age 18-21.

Complications and prognosis

Complications:

Cardiovascular

  • Aortic dissection: Life-threatening complication occurring in 1-2% of women with Turner syndrome, risk significantly elevated during pregnancy. Most common in third or fourth decade.
  • Progressive aortic dilation: Requires monitoring and may necessitate surgical intervention
  • Endocarditis: Increased risk with bicuspid aortic valve
  • Hypertension: Affects 30-50% even without coarctation; contributes to cardiovascular morbidity
  • Ischemic heart disease: Increased risk in adulthood

Metabolic and endocrine

  • Type 2 diabetes mellitus: Risk increased 4-fold compared to general population
  • Obesity: Common in adulthood despite normal BMI in childhood
  • Hypothyroidism: Develops in 15-30%, requiring lifelong treatment
  • Osteoporosis and fractures: Due to estrogen deficiency if untreated; persists even with hormone replacement

Reproductive

  • Infertility: Affects >95% of women with Turner syndrome
  • Pregnancy complications: Spontaneous pregnancy occurs in <5%, but carries extremely high maternal risk including aortic dissection (2% risk), with maternal mortality 100-fold higher than general obstetric population

Gastrointestinal

  • Inflammatory bowel disease: Slight increase in prevalence
  • Celiac disease: 3-6 fold increased risk
  • Gastrointestinal bleeding: Increased risk from telangiectasias

Hearing

  • Progressive sensorineural hearing loss: Affects 50-90% by adulthood
  • Recurrent otitis media: Common in childhood

Other

  • Autoimmune disorders: Increased risk of autoimmune thyroiditis, vitiligo, alopecia, juvenile idiopathic arthritis
  • Renal complications: Hypertension, recurrent urinary tract infections with structural anomalies
  • Liver disease: Elevated transaminases, non-alcoholic fatty liver disease, rare cases of cirrhosis

Prognosis:

Life expectancy in Turner syndrome is reduced by approximately 10-13 years compared to the general female population, with a median age of death in the late 60s to early 70s. Cardiovascular disease is the leading cause of excess mortality, accounting for approximately 40% of deaths.

With modern multidisciplinary care including growth hormone therapy, hormone replacement, and cardiovascular surveillance, quality of life and outcomes have significantly improved. Most women with Turner syndrome:

  • Achieve adult heights of 147-150 cm with growth hormone therapy
  • Develop normal secondary sexual characteristics with hormone replacement
  • Live independently and have successful careers
  • Can pursue higher education at rates similar to the general population
  • May become mothers through oocyte donation, though pregnancy carries substantial risks

Mosaic karyotypes (45,X/46,XX) generally have milder phenotypes, higher rates of spontaneous puberty (30-40%), and occasional spontaneous fertility.

Regular lifelong medical surveillance is essential to detect and manage complications early. Women with Turner syndrome should be followed by specialists experienced in the condition. The most critical aspect of long-term management is cardiovascular monitoring to prevent life-threatening aortic complications.

Mnemonic

TURNER: Tall gonadotropins, Underdeveloped ovaries, Renal anomalies, Neck webbing, Edema (lymphedema), Radial/cardiac defects

Practice questions

1. A 14-year-old girl is brought to the clinic by her mother for evaluation of absent menstrual periods. She is the shortest student in her class at 142 cm (4 feet 8 inches). Physical examination reveals a low posterior hairline, webbed neck, widely spaced nipples, and cubitus valgus. A systolic murmur is heard at the right upper sternal border. Breast development is Tanner stage 1. Which of the following laboratory findings is most likely?

Answer: B. This patient's presentation is classic for Turner syndrome: short stature, primary amenorrhea, characteristic dysmorphic features (webbed neck, widely spaced nipples, cubitus valgus), and absent pubertal development. The cardiac murmur suggests an associated congenital heart defect, likely bicuspid aortic valve or coarctation. Turner syndrome causes gonadal dysgenesis with streak ovaries that cannot produce estrogen or provide negative feedback, resulting in markedly elevated FSH and LH (hypergonadotropic hypogonadism). Karyotype would confirm the diagnosis.

2. A 6-year-old girl is referred to endocrinology for short stature. Her height is below the 3rd percentile and growth velocity has been declining. Karyotype analysis reveals 45,X. Echocardiogram shows a bicuspid aortic valve. In addition to growth hormone therapy, which of the following studies should be performed as part of initial evaluation?

Answer: B. Turner syndrome is associated with multiple congenital anomalies. Renal abnormalities occur in 30-40% of patients, including horseshoe kidney (most common), duplicated collecting systems, and renal hypoplasia. Renal ultrasound is a standard part of the initial evaluation once Turner syndrome is diagnosed. Other recommended baseline studies include thyroid function tests, celiac screening, liver function tests, and audiology assessment. While cardiac evaluation is already completed in this patient, comprehensive screening for associated conditions is essential.

3. A 28-year-old woman with Turner syndrome managed with growth hormone during childhood and estrogen replacement since age 12 presents for preconception counseling. She wishes to attempt pregnancy spontaneously, which is unusual given her diagnosis. Karyotype performed in childhood showed 45,X/46,XX mosaicism. She has a bicuspid aortic valve but no history of coarctation. Blood pressure is 118/74 mmHg. Which of the following is the most important next step?

Answer: B. Pregnancy in Turner syndrome carries extremely high maternal cardiovascular risk, particularly aortic dissection (approximately 2% risk), with maternal mortality rates 100-fold higher than the general obstetric population. Before considering pregnancy, comprehensive cardiovascular evaluation including cardiac MRI to measure aortic dimensions is mandatory. Pregnancy is contraindicated if the aortic diameter exceeds specific thresholds (typically aortic size index >2 cm/m²). Even with mosaicism and bicuspid aortic valve as the only cardiac finding, this patient requires thorough assessment before proceeding with pregnancy to determine if the risks are acceptable.

Frequently asked questions

What causes Turner syndrome?

Turner syndrome is caused by complete or partial absence of one X chromosome in females. About 50-60% of cases have complete monosomy X (45,X karyotype), 15-25% have mosaicism (such as 45,X/46,XX), and the remainder have structural abnormalities of the X chromosome like isochromosome Xq or ring X. The condition occurs sporadically, is not inherited, and is not associated with maternal age. It results from errors during meiosis or early embryonic cell division.

What are the first symptoms of Turner syndrome?

The earliest signs of Turner syndrome are often detected at birth or in infancy, including lymphedema of the hands and feet, webbed neck (in 25-40%), low-set ears, and wide-spaced nipples. However, many girls are not diagnosed until later childhood when short stature becomes apparent, or during adolescence when puberty fails to start and primary amenorrhea prompts evaluation. Some cases are now detected prenatally through ultrasound findings like increased nuchal translucency or cystic hygroma, or through cell-free DNA screening.

How is Turner syndrome diagnosed?

Turner syndrome is diagnosed by karyotype analysis of peripheral blood lymphocytes, which reveals 45,X (in 50-60%), mosaicism, or structural X chromosome abnormalities. At least 20-30 cells should be analyzed to detect low-level mosaicism. The diagnosis is typically suspected based on clinical features like unexplained short stature, delayed puberty, or primary amenorrhea. Hormonal testing shows markedly elevated FSH and LH (FSH typically >30-40 IU/L) with low estradiol after age 10-11, confirming gonadal dysgenesis.

Is Turner syndrome curable?

Turner syndrome is not curable because it is a chromosomal condition present from conception. However, it is very treatable with lifelong management that significantly improves outcomes. Growth hormone therapy increases final adult height by 5-10 cm. Estrogen replacement therapy induces puberty, maintains bone health, and supports overall well-being. Regular screening and management of associated conditions like cardiac defects, hypothyroidism, and diabetes allow most women with Turner syndrome to live healthy, independent, and fulfilling lives, though life expectancy is somewhat reduced compared to the general population.

Turner syndrome vs Noonan syndrome — what is the difference?

While both syndromes share overlapping features like short stature, webbed neck, and cardiac defects, they are distinct conditions. Turner syndrome occurs only in phenotypic females with 45,X or related X chromosome abnormalities, causes gonadal dysgenesis with elevated gonadotropins, and is associated with bicuspid aortic valve and coarctation of the aorta. Noonan syndrome affects both males and females with normal karyotypes (46,XX or 46,XY), is caused by mutations in RAS/MAPK pathway genes, typically features pulmonary stenosis rather than left-sided cardiac lesions, and patients have normal or early puberty with normal fertility potential.

Key drugs

somatropinestradiolconjugated estrogensmedroxyprogesteronemicronized progesteronelevothyroxinecalciumvitamin D
Noonan syndromePrimary ovarian insufficiencyGrowth hormone deficiencyCongenital hypothyroidismAndrogen insensitivity syndromeCoarctation of the aortaBicuspid aortic valveKallmann syndrome

Sources and further reading

StatPearls (NCBI Bookshelf)MedlinePlusWHO ICD-10: Q96

Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.